World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
110
Citations
51302
World Ranking
539
National Ranking
12

Medicine

D-Index
110
Citations
51395
World Ranking
5496
National Ranking
206

Overview

Michel D. Ferrari is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on medicine, with a significant number of publications in psychiatry and mental health, pathology and forensic medicine, physiology, neurology, and pulmonary and respiratory medicine.

The scientist's work covers several main topics, notably:

  • Migraine and Headache Studies
  • Trigeminal Neuralgia and Treatments
  • Sympathectomy and Hyperhidrosis Treatments
  • Olfactory and Sensory Function Studies
  • Cerebrovascular and Carotid Artery Diseases
  • Neuroscience of Respiration and Sleep
  • Vestibular and Auditory Disorders

Michel D. Ferrari frequently publishes in several journals, including:

  • Cephalalgia
  • Journal of the American College of Cardiology
  • Neurology
  • Annals of Neurology
  • Headache The Journal of Head and Face Pain

Some recent papers include:

  • "European Position Paper on Rhinosinusitis and Nasal Polyps 2020" (2020), published in Rhinology Journal
  • "Migraine" (2022), published in Nature Reviews Disease Primers
  • "Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults" (2020), published in Cephalalgia
  • "Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice" (2020), published in Annals of Neurology
  • "A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine" (2020), published in Nature Communications

Frequent co-authors collaborating with Michel D. Ferrari include:

  • Gisela M. Terwindt
  • Rolf Fronczek
  • Arn M. J. M. van den Maagdenberg
  • Roemer B. Brandt
  • Erik W. van Zwet

Best Publications

  • Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4

    Roel A. Ophoff;Gisela M. Terwindt;Monique N. Vergouwe;Ronald Van Eijk

  • Migraine--current understanding and treatment.

    Peter J. Goadsby;Richard B. Lipton;Michel D. Ferrari

  • Analysis of shared heritability in common disorders of the brain

    Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters

  • Coding of facial expressions of pain in the laboratory mouse

    Dale J Langford;Andrea L Bailey;Mona Lisa Chanda;Sarah E Clarke

  • Migraine as a Risk Factor for Subclinical Brain Lesions

    Mark C. Kruit;Mark A. van Buchem;Paul A. M. Hofman;Jacobus T. N. Bakkers

  • Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials

    Michel D Ferrari;Krista I Roon;Richard B Lipton;Peter J Goadsby

  • Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.

    Martin Dichgans;Tobias Freilinger;Gertrud Eckstein;Elena Babini

  • A Cacna1a Knockin Migraine Mouse Model with Increased Susceptibility to Cortical Spreading Depression

    Arn M.J.M van den Maagdenberg;Daniela Pietrobon;Tommaso Pizzorusso;Simon Kaja

  • Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine

    Padhraig Gormley;Verneri Anttila;Verneri Anttila;Bendik S. Winsvold;Bendik S. Winsvold;Priit Palta

  • Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

    Tony W Ho;Michel D Ferrari;David W Dodick;Vince Galet

  • Migraine

    Unknown

  • Cardiovascular risk factors and migraine The GEM population-based study

    A. I. Scher;G. M. Terwindt;H. S.J. Picavet;W. M.M. Verschuren

  • Genome-wide association study reveals three susceptibility loci for common migraine in the general population.

    Daniel I Chasman;Markus Schürks;Markus Schürks;Verneri Anttila;Verneri Anttila;Boukje de Vries

  • Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.

    Uwe Reuter;Peter J Goadsby;Michel Lanteri-Minet;Shihua Wen

  • Genome-wide meta-analysis identifies new susceptibility loci for migraine

    Verneri Anttila;Bendik S. Winsvold;Bendik S. Winsvold;Padhraig Gormley;Tobias Kurth

  • Infarcts in the Posterior Circulation Territory in Migraine. The Population-Based MRI CAMERA Study

    Mark C. Kruit;Lenore J. Launer;Michel D. Ferrari;Mark A. van Buchem

  • C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy

    Anna Richards;Arn M J M Van Den Maagdenberg;Joanna C. Jen;David Kavanagh

  • Ergotamine in the acute treatment of migraine: a review and European consensus.

    P. Tfelt-Hansen;P. R. Saxena;C. Dahlof;J. Pascual

  • De novo mutations in ATP1A3 cause alternating hemiplegia of childhood

    Erin L Heinzen;Kathryn J Swoboda;Yuki Hitomi;Fiorella Gurrieri

  • Delayed cerebral edema and fatal coma after minor head trauma : role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine

    Esther E. Kors;Gisela M. Terwindt;Frans L.M.G. Vermeulen;Robin B. Fitzsimons

  • Migraine pathophysiology: lessons from mouse models and human genetics

    Michel D Ferrari;Roselin R Klever;Gisela M Terwindt;Cenk Ayata

  • Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions.

    Kaate R.J. Vanmolkot;Esther E. Kors;Jouke Jan Hottenga;Gisela M. Terwindt

Frequent Co-Authors

Arn M. J. M. van den Maagdenberg
Arn M. J. M. van den Maagdenberg Leiden University Medical Center
Rune R. Frants
Rune R. Frants Leiden University
Peter J. Goadsby
Peter J. Goadsby King's College London
Lenore J. Launer
Lenore J. Launer National Institutes of Health
Mark A. van Buchem
Mark A. van Buchem Leiden University Medical Center
Martin Dichgans
Martin Dichgans Ludwig-Maximilians-Universität München
Aarno Palotie
Aarno Palotie University of Helsinki
Dale R. Nyholt
Dale R. Nyholt Queensland University of Technology
Roel A. Ophoff
Roel A. Ophoff University of California, Los Angeles
Richard B. Lipton
Richard B. Lipton Albert Einstein College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience can lead to diverse and rewarding career opportunities. If you're interested in expanding your credentials, there are several certifications that pay well that may complement your background in neuroscience, such as data analysis or health informatics certifications.

For those considering a more accessible academic path, starting out with the easiest online bachelor's degree options can help you build a foundation. Later, you might specialize in neuroscience or pursue related fields.

Careers in mental health and social work also align closely with neuroscience studies. An msw degree (Master of Social Work) prepares graduates for clinical and advocacy roles where neuroscience knowledge is a valuable asset.

Additionally, becoming a Board Certified Behavior Analyst is another pathway. Affordable, flexible options exist, and you can complete a bcba degree online to work directly with clients in educational and therapeutic settings.

Best Scientists Citing Michel D. Ferrari

Trending Scientists

Recently Published Articles